CORD-19:8c51cf0cc444f6a851ad178040369984759ddfec / 1769-2035 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T14","span":{"begin":0,"end":266},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"As is shown in Table 1 , these retinopathies can be categorized into three groups: (i) visual paraneoplastic disorders, frequently referred to as cancer-associated retinopathies (CAR), (ii) infection-associated retinopathies and (iii) retinal degenerative disorders."}

{"project":"Epistemic_Statements","denotations":[{"id":"T12","span":{"begin":0,"end":266},"obj":"Epistemic_statement"}],"text":"As is shown in Table 1 , these retinopathies can be categorized into three groups: (i) visual paraneoplastic disorders, frequently referred to as cancer-associated retinopathies (CAR), (ii) infection-associated retinopathies and (iii) retinal degenerative disorders."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T14","span":{"begin":0,"end":266},"obj":"Sentence"}],"text":"As is shown in Table 1 , these retinopathies can be categorized into three groups: (i) visual paraneoplastic disorders, frequently referred to as cancer-associated retinopathies (CAR), (ii) infection-associated retinopathies and (iii) retinal degenerative disorders."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T4","span":{"begin":146,"end":152},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"As is shown in Table 1 , these retinopathies can be categorized into three groups: (i) visual paraneoplastic disorders, frequently referred to as cancer-associated retinopathies (CAR), (ii) infection-associated retinopathies and (iii) retinal degenerative disorders."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3","span":{"begin":146,"end":177},"obj":"Disease"},{"id":"T4","span":{"begin":146,"end":152},"obj":"Disease"},{"id":"T5","span":{"begin":179,"end":182},"obj":"Disease"},{"id":"T6","span":{"begin":190,"end":199},"obj":"Disease"},{"id":"T7","span":{"begin":243,"end":265},"obj":"Disease"},{"id":"T88411","span":{"begin":146,"end":177},"obj":"Disease"},{"id":"T79372","span":{"begin":146,"end":152},"obj":"Disease"},{"id":"T72754","span":{"begin":179,"end":182},"obj":"Disease"},{"id":"T72258","span":{"begin":190,"end":199},"obj":"Disease"},{"id":"T76740","span":{"begin":243,"end":265},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0019112"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0019112"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0024236"},{"id":"A37088","pred":"mondo_id","subj":"T88411","obj":"http://purl.obolibrary.org/obo/MONDO_0019112"},{"id":"A41424","pred":"mondo_id","subj":"T79372","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A48498","pred":"mondo_id","subj":"T72754","obj":"http://purl.obolibrary.org/obo/MONDO_0019112"},{"id":"A64397","pred":"mondo_id","subj":"T72258","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A13496","pred":"mondo_id","subj":"T76740","obj":"http://purl.obolibrary.org/obo/MONDO_0024236"}],"text":"As is shown in Table 1 , these retinopathies can be categorized into three groups: (i) visual paraneoplastic disorders, frequently referred to as cancer-associated retinopathies (CAR), (ii) infection-associated retinopathies and (iii) retinal degenerative disorders."}